• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Bristol-Myers Squibb (NY:BMY)

    43.63 +0.24 (+0.55%)
    Official Closing Price Updated: 4:10 PM EDT, Oct 17, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 13,903,795
    Open 43.28
    Bid (Size) 43.55 (1)
    Ask (Size) 43.63 (3)
    Prev. Close 43.39
    Today's Range 43.10 - 43.66
    52wk Range 42.96 - 63.33
    Shares Outstanding 2,222,113,553
    Dividend Yield 5.68%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    3 S&P 500 Stocks We Find Risky
    The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
    Via StockStory
    Topics Stocks
    This Drug Discovery Stock Is Leading the Charge In Bringing AI to Healthcare. But Is It a Buy?
    All of the top 20 drugmakers have a subscription with this software business. 
    Via The Motley Fool
    Topics Artificial Intelligence

    Performance

    YTD
    -23.2%
    -23.2%
    1 Month
    -5.8%
    -5.8%
    3 Month
    -9.2%
    -9.2%
    6 Month
    -11.4%
    -11.4%
    1 Year
    -18.2%
    -18.2%

    More News

    Read More
    Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 3% Dividend Yields
    Via Benzinga
    Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types
    From Bristol Myers Squibb
    Via Business Wire
    Bristol Myers Squibb To Acquire Orbital Therapeutics In $1.5B Deal
    Via Stocktwits
    Price Over Earnings Overview: Bristol-Myers Squibb
    Via Benzinga
    Branded Pharmaceuticals Stocks Q2 Earnings Review: Supernus Pharmaceuticals (NASDAQ:SUPN) Shines
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    Bristol Myers Expands Cell Therapy Portfolio With Orbital Therapeutics Acquisition
    Via Benzinga
    Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics
    From Bristol Myers Squibb
    Via Business Wire
    Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection
    From Bristol Myers Squibb
    Via Business Wire
    3 Value Stocks with Warning Signs
    Via StockStory
    BRISTOL-MYERS SQUIBB CO (NYSE:BMY) Offers a High Dividend Yield and Strong Profitability
    Via Chartmill
    BRISTOL-MYERS SQUIBB CO (NYSE:BMY) Presents a Strong Value Investment Case
    Via Chartmill
    These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap
    Via Benzinga
    What's going on in today's session: S&P500 movers
    Via Chartmill
    Nanobiotix Stock Soars on Breakthrough Esophageal Cancer Data, Igniting Biotech Hopes
    Via MarketMinute
    Healthcare Sector Defies Headwinds, Rallies on Wall Street Amidst Shutdown and Jobs Data
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    In today's session, there are S&P500 stocks with remarkable trading volume.
    Via Chartmill
    Health Care Stocks Rally, Nike Beats The Street: What's Moving Markets Wednesday?
    Via Benzinga
    Why Is Bristol-Myers Squibb (BMY) Stock Rocketing Higher Today
    Via StockStory
    Topics Artificial Intelligence
    Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields
    Via Benzinga
    Bristol Myers Squibb’s Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimer’s Disease
    From Bristol Myers Squibb
    Via Business Wire
    Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge
    Via MarketMinute
    Topics Economy Government World Trade
    Trump's Plan To Lower U.S. Drug Prices Faces Big Test
    Via Investor's Business Daily
    Topics Government
    Merus N.V. Soars on $8 Billion Genmab Acquisition, Propelled by Oncology Pipeline Successes
    Via MarketMinute

    Frequently Asked Questions

    Is Bristol-Myers Squibb publicly traded?
    Yes, Bristol-Myers Squibb is publicly traded.
    What exchange does Bristol-Myers Squibb trade on?
    Bristol-Myers Squibb trades on the New York Stock Exchange
    What is the ticker symbol for Bristol-Myers Squibb?
    The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
    What is the current price of Bristol-Myers Squibb?
    The current price of Bristol-Myers Squibb is 43.63
    When was Bristol-Myers Squibb last traded?
    The last trade of Bristol-Myers Squibb was at 10/17/25 04:10 PM ET
    What is the market capitalization of Bristol-Myers Squibb?
    The market capitalization of Bristol-Myers Squibb is 96.95B
    How many shares of Bristol-Myers Squibb are outstanding?
    Bristol-Myers Squibb has 97B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.